4 Articles found
Ancora Heart, Inc Articles
-
An evaluation of the AccuCinch Ventricular Restoration System in symptomatic heart failure patients with reduced ejection fraction (HFrEF) - Case Study
Study Overview: Design: Prospective, randomized, open-label, multi-center, international, clinical safety and efficacy investigation. Randomization: Treatment with AccuCinch System plus guideline-directed medical therapy (GDMT) or GDMT alone. ...
-
Doctors at NaHomolce Hospital in Prague perform AccuCinch Procedure in Patient with Heart Failure - Patient Case Study at Na Homolce Hospital
February 1, Prague/ Udalosti. The epidemic called “Chronic Heart Failure” affects up to half a million Czechs. An innovation being tested at Prague’s Na Homolce Hospital could be a turning point in the care of these patients. A ...
-
Ancora Heart sees positive early results with Accucinch in systolic heart failure
Ancora Heart Inc., a Santa Clara, Calif.-based company looking to help those with heart failure, is heralding results from an interim analysis of patients treated in a U.S. early feasibility study evaluating the safety of the investigational ...
-
Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy
Interim study results from systolic heart failure patients treated with percutaneous therapy designed to improve left ventricular function presented at TCT 2019 Santa Clara, Calif.–September 25, 2019–Ancora Heart, Inc., a company ...